Enanta Pharma (ENTA) Tops Q4 EPS by 14c

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of $0.29, $0.14 better than the analyst estimate of $0.15. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $16.44 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg